Literature DB >> 19995649

Gender-associated differences in lung cancer: clinical characteristics and treatment outcomes in women.

Seema Harichand-Herdt1, Suresh S Ramalingam.   

Abstract

Lung cancer is the leading cause of cancer deaths in the United States. In recent years the incidence of lung cancer in men has been declining, while in women it has been increasing. A number of population-based studies have demonstrated gender-based differences in clinical and pathologic factors, as well as in survival related to lung cancer. Disparities in age, smoking practices, and histological subtypes are among the differences that have been identified. Gender disparity also has been observed in outcomes, with improved survival observed for women in a number of clinical trials. This article reviews the gender-related differences in clinical and pathologic factors and outcomes of patients with lung cancer observed in population-based studies and clinical trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995649     DOI: 10.1053/j.seminoncol.2009.10.007

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  18 in total

Review 1.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

2.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Overexpression and gender-specific differences of SRC-3 (SRC-3/AIB1) immunoreactivity in human non-small cell lung cancer: an in vivo study.

Authors:  Haidong Wang; Dongmei Zhang; Wei Wu; Jiqiang Zhang; Deyu Guo; Qingliang Wang; Tao Jing; Chengping Xu; Xiuwu Bian; Kang Yang
Journal:  J Histochem Cytochem       Date:  2010-09-17       Impact factor: 2.479

4.  Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

Authors:  Helena A Yu; Maria E Arcila; Natasha Rekhtman; Camelia S Sima; Maureen F Zakowski; William Pao; Mark G Kris; Vincent A Miller; Marc Ladanyi; Gregory J Riely
Journal:  Clin Cancer Res       Date:  2013-03-07       Impact factor: 12.531

5.  Sex differences in early outcomes after lung cancer resection: analysis of the Society of Thoracic Surgeons General Thoracic Database.

Authors:  Betty C Tong; Andrzej S Kosinski; William R Burfeind; Mark W Onaitis; Mark F Berry; David H Harpole; Thomas A D'Amico
Journal:  J Thorac Cardiovasc Surg       Date:  2014-03-14       Impact factor: 5.209

6.  Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease.

Authors:  Rihong Zhai; Xiaojin Yu; Yongyue Wei; Li Su; David C Christiani
Journal:  Int J Cancer       Date:  2013-08-29       Impact factor: 7.396

Review 7.  Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.

Authors:  Rowan T Chlebowski; Garnet L Anderson
Journal:  Steroids       Date:  2014-06-06       Impact factor: 2.668

8.  Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.

Authors:  Sean Khozin; Kenneth R Carson; Jizu Zhi; Melisa Tucker; Shannon E Lee; David E Light; Melissa D Curtis; Marta Bralic; Irene Kaganman; Anala Gossai; Philip Hofmeister; Aracelis Z Torres; Rebecca A Miksad; Gideon Michael Blumenthal; Richard Pazdur; Amy P Abernethy
Journal:  Oncologist       Date:  2018-12-27

9.  Histological subtype and smoking status, but not gender, are associated with epidermal growth factor receptor mutations in non-small-cell lung cancer.

Authors:  Shih-Hsin Hsiao; Sey-En Lin; Yu-Ting Chou; Jinn-Li Wang; Chi-Li Chung; Ming-Chih Yu; Chia-Lang Fang; Hsin-Lun Lee; Ling-Ling Chiang; H Eugene Liu; Cheng-Wen Wu
Journal:  Mol Clin Oncol       Date:  2013-12-23

10.  Age-specific effect of gender on upper tract urothelial carcinoma outcomes.

Authors:  Jian-Ye Liu; Yong-Hong Li; Zhi-Ling Zhang; Yun-Lin Ye; Zhou-Wei Liu; Kai Yao; Pei Dong; Sheng-Jie Guo; Li-Juan Jiang; Ming-Zhu Zhong; Wei Chen; Hui Han; Zi-Ke Qin; Fang-Jian Zhou
Journal:  Med Oncol       Date:  2013-06-19       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.